论文部分内容阅读
目的探讨中药结合干扰素联合化疗治疗晚期非小细胞肺癌对患者生存质量的影响。方法将非小细胞肺癌患者200例随机分为研究组及对照组各100例,对照组应用干扰素联合化疗治疗,观察组采取中药结合干扰素联合化疗治疗,对比2组患者近期疗效及生存质量。结果研究组有效率为86.00%高于对照组的70.00%,治疗后研究组生存质量评分低于治疗前及对照组,差异均有统计学意义(P<0.05)。对照组治疗前后生活质量评分比较差异无统计学意义(P>0.05)。结论中药结合干扰素联合化疗治疗晚期非小细胞肺癌可有效改善患者病情,并能提升患者生存质量,值得推广。
Objective To investigate the effect of traditional Chinese medicine combined with interferon plus chemotherapy on the quality of life of patients with advanced non-small cell lung cancer. Methods 200 cases of non-small cell lung cancer patients were randomly divided into study group and control group of 100 cases, the control group treated with interferon combined with chemotherapy, the observation group to take traditional Chinese medicine combined with interferon plus chemotherapy, compared two groups of patients with short-term efficacy and quality of life . Results The effective rate of the study group was 86.00%, which was higher than that of the control group (70.00%). After treatment, the quality of life in the study group was lower than that before treatment and in the control group (P <0.05). There was no significant difference in quality of life before and after treatment in the control group (P> 0.05). Conclusion Traditional Chinese medicine combined with interferon plus chemotherapy in the treatment of advanced non-small cell lung cancer can effectively improve the patient’s condition, and improve the quality of life of patients, worthy of promotion.